Gregory B. Haber, MD, MASGE

“I never imagined that such an esteemed award would be bestowed upon me. It still feels somewhat surreal as I accept this recognition from my colleagues and friends in our society and in our specialty. An honor as high as the Schindler Award can only be achieved by standing on the shoulders of so many who molded and inspired my career. My aspirations to do something meaningful and to save lives was instilled very early on by my parents and fueled by my fascination with medicine. As the years unfolded, I realized my natural bent and talent was drawn to gastroenterology and, in particular, endoscopy. The minimally invasive therapeutic side of endoscopy gave me the reward of not only diagnosing but curing disease. My career then advanced one small step following another, with a new revelation at each turn and a mentor to guide me. The fascination with novel ways to achieve better outcomes for our patients has not faded. In fact, it is the motivation to continue to explore new concepts and new technologies. I am grateful to the countless brilliant, dedicated and generous members of our society who exemplify these virtues and make all of this possible for disciples like me. Finally, I want to recognize my wife and family for their unwavering support in nurturing my roots and providing me a home that has allowed me to thrive.”

Dr. Haber is a professor of medicine and biochemistry and molecular pharmacology, the chief of endoscopy and the director of the Center for Advanced Therapeutics and Innovation, Division of Gastroenterology, Department of Medicine, NYU Langone Health in New York.

Dr. Haber is one of the world’s foremost experts in clinical care and education in advanced therapeutic endoscopy. He has dedicated himself to the mentorship of the next generation of physicians in these techniques and technologies, having trained more than 60 advanced fellows.

After receiving his medical degree from the University of Toronto, Dr. Haber completed his training in internal medicine and gastroenterology. He subsequently received a Medical Research Council of Canada grant to do postgraduate research in bile acid metabolism at the Bristol Royal Infirmary in Bristol, England. He returned to the University of Toronto as a consultant at The Wellesley Hospital and St. Michael’s Hospital, which is where the university’s advanced endoscopy center was established. Dr. Haber was the chief of gastroenterology at Lenox Hill Hospital from 2004 to 2016. He accepted his position at NYU Langone Health in 2016. In 2018, Dr. Haber was honored with the title of professor of medicine and biochemistry and molecular pharmacology by NYU Langone Health.

Dr. Haber has contributed to over 100 scientific publications and over 200 abstracts and has given nearly 400 presentations at educational seminars and conferences nationally and internationally. He frequently serves as a course director for educational conferences, and he was a 2010 recipient of the American Society for Gastrointestinal Endoscopy’s Master of Endoscopy Award.

Dr. Haber’s areas of expertise include advanced resection with ESD, EMR and full thickness resection and third space intervention with POEM for achalasia, gastroparesis, and Zenker’s. He also has a longstanding commitment to pancreatico-biliary disease with ERCP and EUS interventions, including EUS access techniques and ablation.